72 related articles for article (PubMed ID: 20956942)
1. Thyroid hormone receptor β1 domains responsible for the antagonism with the ras oncogene: role of corepressors.
García-Silva S; Martínez-Iglesias O; Ruiz-Llorente L; Aranda A
Oncogene; 2011 Feb; 30(7):854-64. PubMed ID: 20956942
[TBL] [Abstract][Full Text] [Related]
2. Ligand-dependent corepressor acts as a novel corepressor of thyroid hormone receptor and represses hepatic lipogenesis in mice.
Song Y; Shan S; Zhang Y; Liu W; Ding W; Ren W; Xia H; Li X; Zhang Q; Zhao L; Li X; Yan J; Ying H
J Hepatol; 2012 Jan; 56(1):248-54. PubMed ID: 21827732
[TBL] [Abstract][Full Text] [Related]
3. Thyroid hormone receptor beta1 gene expression is increased by Dexamethasone at transcriptional level in rat liver.
Montesinos MM; Pellizas CG; Vélez ML; Susperreguy S; Masini-Repiso AM; Coleoni AH
Life Sci; 2006 Apr; 78(22):2584-94. PubMed ID: 16330054
[TBL] [Abstract][Full Text] [Related]
4. Thyroid hormone receptor-beta (TR beta 1) impairs cell proliferation by the transcriptional inhibition of cyclins D1, E and A2.
Porlan E; Vidaurre OG; Rodríguez-Peña A
Oncogene; 2008 Apr; 27(19):2795-800. PubMed ID: 18037966
[TBL] [Abstract][Full Text] [Related]
5. T3 enhances thyroid cancer cell proliferation through TRβ1/Oct-1-mediated cyclin D1 activation.
Perri A; Catalano S; Bonofiglio D; Vizza D; Rovito D; Qi H; Aquila S; Panza S; Rizza P; Lanzino M; Andò S
Mol Cell Endocrinol; 2014 Jan; 382(1):205-217. PubMed ID: 24121026
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppression by IFN regulatory factor-1 is mediated by transcriptional down-regulation of cyclin D1.
Kröger A; Stirnweiss A; Pulverer JE; Klages K; Grashoff M; Reimann J; Hauser H
Cancer Res; 2007 Apr; 67(7):2972-81. PubMed ID: 17409403
[TBL] [Abstract][Full Text] [Related]
7. Thyroid hormone receptor TRbeta1 mediates Akt activation by T3 in pancreatic beta cells.
Verga Falzacappa C; Petrucci E; Patriarca V; Michienzi S; Stigliano A; Brunetti E; Toscano V; Misiti S
J Mol Endocrinol; 2007 Feb; 38(1-2):221-33. PubMed ID: 17293442
[TBL] [Abstract][Full Text] [Related]
8. Silencing of N-Ras gene expression using shRNA decreases transformation efficiency and tumor growth in transformed cells induced by anti-BPDE.
Zhou L; Jiang Y; Tan A; Greenlee AR; Shen Y; Liu L; Yang Q
Toxicol Sci; 2008 Oct; 105(2):286-94. PubMed ID: 18567617
[TBL] [Abstract][Full Text] [Related]
9. The thyroid hormone receptor is a suppressor of ras-mediated transcription, proliferation, and transformation.
García-Silva S; Aranda A
Mol Cell Biol; 2004 Sep; 24(17):7514-23. PubMed ID: 15314161
[TBL] [Abstract][Full Text] [Related]
10. Thyroid hormone-stimulated differentiation of primary rib chondrocytes in vitro requires thyroid hormone receptor beta.
Rabier B; Williams AJ; Mallein-Gerin F; Williams GR; Chassande O
J Endocrinol; 2006 Oct; 191(1):221-8. PubMed ID: 17065405
[TBL] [Abstract][Full Text] [Related]
11. Critical role of glutamine 252 in the hormone-dependent transcriptional activity of the thyroid hormone beta1 nuclear receptor.
Bhat MK; McPhie P; Cheng S
Biochemistry; 1997 Apr; 36(14):4233-9. PubMed ID: 9100018
[TBL] [Abstract][Full Text] [Related]
12. Identification of the putative MAP kinase docking site in the thyroid hormone receptor-beta1 DNA-binding domain: functional consequences of mutations at the docking site.
Lin HY; Zhang S; West BL; Tang HY; Passaretti T; Davis FB; Davis PJ
Biochemistry; 2003 Jun; 42(24):7571-9. PubMed ID: 12809513
[TBL] [Abstract][Full Text] [Related]
13. The thyroid hormone receptor (TR) beta-selective agonist GC-1 inhibits proliferation but induces differentiation and TR beta mRNA expression in mouse and rat osteoblast-like cells.
Beber EH; Capelo LP; Fonseca TL; Costa CC; Lotfi CF; Scanlan TS; Gouveia CH
Calcif Tissue Int; 2009 Apr; 84(4):324-33. PubMed ID: 19280098
[TBL] [Abstract][Full Text] [Related]
14. Suppression of malignant growth potentials of v-Src-transformed human gallbladder epithelial cells by adenovirus-mediated dominant negative H-Ras.
Tokumitsu Y; Nakano S; Ueno H; Niho Y
J Cell Physiol; 2000 May; 183(2):221-7. PubMed ID: 10737897
[TBL] [Abstract][Full Text] [Related]
15. c-Jun NH2-terminal kinase 2 is required for Ras transformation independently of activator protein 1.
Nielsen C; Thastrup J; Bøttzauw T; Jäättelä M; Kallunki T
Cancer Res; 2007 Jan; 67(1):178-85. PubMed ID: 17210697
[TBL] [Abstract][Full Text] [Related]
16. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
Su ZZ; Austin VN; Zimmer SG; Fisher PB
Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
[TBL] [Abstract][Full Text] [Related]
17. The TRbeta1 is essential in mediating T3 action on Akt pathway in human pancreatic insulinoma cells.
Verga Falzacappa C; Patriarca V; Bucci B; Mangialardo C; Michienzi S; Moriggi G; Stigliano A; Brunetti E; Toscano V; Misiti S
J Cell Biochem; 2009 Apr; 106(5):835-48. PubMed ID: 19160403
[TBL] [Abstract][Full Text] [Related]
18. Suppression of cellular transformation by glucocorticoid receptor mutants.
Kameda T; Iba H
Cancer Res; 1998 Mar; 58(5):867-70. PubMed ID: 9500440
[TBL] [Abstract][Full Text] [Related]
19. Transformation suppressor activity of a Jun transcription factor lacking its activation domain.
Lloyd A; Yancheva N; Wasylyk B
Nature; 1991 Aug; 352(6336):635-8. PubMed ID: 1907719
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH
Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
